Industry Overview:
The global automated iv compounding market is estimated to reach USD 2,000.1 million in 2025, reflecting a growth Y-O-Y of 8.9%. Gaining growth by higher preferences for safe and precise IV therapies in oncology, parenteral nutrition and critical care in a hospitals and compounding pharmacies. Expanding healthcare infrastructure investments and stricter regulatory are required for sterile compounding with shifting from manual to automated systems which are boosting adoption. Recent advancement in technological such as robotic arms with multi-stage compounding and cloud-enabled workflow management. These innovations are supporting to improving efficiency and reducing contamination risks to enabling higher output are driving market expansion across hospitals, specialized clinics and pharmacy networks across the globe.
Industry Insights: Scale, Segments, and Shifts
• Market Size & Growth: The global automated iv compounding market is projected to reach USD 4,606.2 million by 2035, registering a CAGR of 8.7% between 2025 and 2035.
• Segment Analysis: Robotic compounding systems anticipated 55% of the share to their enhancing high adoption in oncology and TPN applications, while automated compounding devices expected to witness growth through the hospitals and compounding pharmacies are looking for safety and less time taking compliances process.
• Regional Highlights: North America captured 38% of the market share in 2024 due to advanced pharmacy automation infrastructure, while Asia-Pacific expected to drives growth through the large scale of availability of government initiatives for modern hospital setups.
• Competitive Landscape: The market is moderately consolidated, with competitors such as B. Braun Melsungen AG, Omnicell, Inc., and ICU Medical, Inc. These players are focusing to proving support to developing advances technologies and enhancing strong strategic collaborations with local players to enhance safety and adoption in healthcare facilities.
Factors Shaping the Next Decade
• Market Gaps / Restraints: High upfront cost required for robotic compounding systems and shortage of skilled staff or technician to operate and validation is mandatory for automation is key restrain in cost-sensitive regions.
• Key Trends and Innovations: The industry is witnessing a transformation of adapting innovations such as robotic compounding systems with gravimetric verification and integration of connected cloud-based workflow management. Rapid deployment of real-time monitoring and compact robotic arms is improving accuracy which helps to reducing contamination risks and enhancing operational efficiency in sterile IV preparation.
• Potential Opportunities: Expansion of modular robotic compounding systems in mid-sized hospitals and adoption of robot-as-a-service models, while growing implementation in specialty outpatient clinics are expected to generate new revenue streams in the upcoming period driven by the need for safety and scalable automation in sterile IV preparation.
Recent Industry Updates:
• December 2025: Fresenius Kabi company has expanded its portfolio such as KabiHelp® Pro PN automated pumping compounding systems are supporting safer and more efficient parenteral nutrition preparation in hospitals and specialty clinics.
• July 2025: ICU Medical unveiled its Diana™ automated compounding system in North American hospitals to increase efficiency in IV preparation and improve regulatory compliance.
• June 2025: B. Braun launched the DUPLEX® Two-Compartment of IV System to enhanced automation capabilities and it enables to safer sterile compounding for parenteral nutrition and oncology therapies.
Industry Outlook Scope:
By Product Type
• Robotic Compounding Systems
• Automated Compounding Devices
• Software Solutions
• Others
By Application
• Chemotherapy
• Parenteral Nutrition
• Antibiotics
• Others
By End-User
• Hospitals
• Compounding Pharmacies
• Ambulatory Surgical Centers
• Others
Geographical Insights: Emerging Corridors of Growth
• Regional Overview: While Europe is fastest growing economy to contribute for growth due to increasing adoption of advanced pharmacy automation and stringent hospital safety standards. The Middle East and Africa are gaining momentum driven by expanding hospital infrastructure and government are supported to the healthcare modernization initiatives. In South America is witnessing fastest growth by private healthcare investments with expanding specialty clinics and focus on clinical efficiency.
• Countries to Watch: Germany continues to lead market due to increasing innovation and pharmacy automation standards and Brazil is showing to capture market through the government providing funding, while South Africa is seeing adoption due to healthcare facility upgrades and regulatory encouragement for sterile compounding automation.
Download Free Regional Sample Report
Regulatory Environment and Policy Support
• Government Regulations & Supportive Policies: Global automated iv compounding manufacturers align with USP <797> for sterile compounding and USP <800> for hazardous drugs to handling in healthcare settings standards are ensuring sterility with also containment and safety compliance. These frameworks are promoting to the adoption of robotic compounding systems and closed-system automation in hospitals and compounding pharmacies.
• Key Government Initiatives: Programs such as the U.S. Compounding Quality Act and supportive state-level initiatives are encouraged to expanding investments in automated IV compounding technologies and safer sterile preparation with minimizing human error and ensuring compliance with regulatory requirements.
Competitive Landscape and Strategic Outlook
The automated iv compounding industry is moderately consolidated, with dominant players are expanding their presences through the support for product innovation with acquisitions and strategic alliances. Global prominent manufacturers are focusing to increase efficiency as well as security on robotic automation with workflow integration and data-driven compounding systems. The small and mis sized new comers are introducing service-based models and cloud-enabled monitoring to strengthen market position and drive adoption across hospitals and compounding pharmacies especially the emerging players in Europe and Latin America are gaining traction through accessible and scalable modular systems.
Industry Competition:
• Baxter International Inc.
• Becton, Dickinson and Company (BD)
• Omnicell, Inc.
• ICU Medical, Inc.
• Grifols, S.A.
• Fresenius Kabi AG
• ARxIUM Inc.
• Equashield LLC
• NewIcon Oy
• Health Robotics S.r.l. (a subsidiary of Omnicell)
• B. Braun Melsungen AG
• JVM Co., Ltd.
• Parata Systems, LLC
• Swisslog Healthcare.
Analyst Perspective
The automated iv compounding market is expected to see rising adoption in specialty clinics, oncology centers and large hospital networks which driven due to increasing demand for precision, sterility and workflow efficiency. In the coming next three to five years, growth will be expected to drives by availability of the large scale of investments in compact robotic systems with cloud-connected monitoring and training programs will accelerate operational reliability. Early movers who integrate scalable automation with regulatory compliance and staff upskilling are likely to achieve faster return on investment and strengthen their market position in a competitive healthcare automation landscape.
What to Expect from Outlook:
1. Save time carrying out entry-level research by identifying the size, growth trends, major segments, and leading companies in the global automated iv compounding market.
2. Use PORTER’s Five Forces analysis to assess the competitive intensity and overall attractiveness of the global automated iv compounding market sector.
3. Profiles of leading companies provide insights into key players’ regional operations, strategies, financial results, and recent initiatives.
4. Add weight to presentations and pitches by understanding the future growth prospects of the global automated iv compounding market with a forecast for the decade by both market share (%) & revenue (USD Million).
1. Introduction
1.1. Executive Summary
1.2. Regional Snapshot
1.3. Market Scope
1.4. Market Definition
2. Across The
Globe
2.1. Factors Affecting End Use Industries
2.2. Market Dynamics
2.2.1. Upcoming Opportunities
2.2.2. Ongoing Market Trends
2.2.3. Growth Driving Factors
2.2.4. Restraining Factors
2.3. Value Chain Analysis
2.3.1. List of Manufacturers
2.3.2. List of Distributors/Suppliers
2.3.3. List of End Users
2.4. PORTER’s & PESTLE Analysis
2.5. Key Developments
2.6. Key Regulations & Certifications
3. Global LED
Driver Market Overview, By Luminaire Type
3.1. Market Size (US$ Mn) Analysis, 2020 –
2035
3.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
3.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
3.3.1. Decorative Lamps
3.3.2. Reflector Lamps
3.3.3. Type A Lamp
3.3.4. Others
4. Global LED
Driver Market Overview, By Component
4.1. Market Size (US$ Mn) Analysis, 2020 –
2035
4.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
4.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
4.3.1. Driver IC
4.3.2. Discrete Component
4.3.3. Others
5. Global LED
Driver Market Overview, By Supply Type
5.1. Market Size (US$ Mn) Analysis, 2020 –
2035
5.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
5.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
5.3.1. Constant Current
5.3.2. Constant Voltage
6. Global LED
Driver Market Overview, By Application
6.1. Market Size (US$ Mn) Analysis, 2020 –
2035
6.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
6.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
6.3.1. Consumer Electronics
6.3.2. General Lighting
6.3.3. Automotive
6.3.4. Outdoor Displays
6.3.5. Others
7. Global LED
Driver Market Overview, By Region
7.1. Market Size (US$ Mn) Analysis, 2020 –
2035
7.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
7.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Middle East & Africa
7.3.5. South America
8. North America
LED Driver Market Overview
8.1. Market Size (US$ Mn) Analysis, 2020 –
2035
8.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
8.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
8.3.1. By Country
8.3.1.1. U.S.
8.3.1.2. Canada
8.3.1.3. Mexico
8.3.2. By Luminaire Type
8.3.3. By Component
8.3.4. By Supply Type
8.3.5. By Application
9. Europe LED
Driver Market Overview
9.1. Market Size (US$ Mn) Analysis, 2020 –
2035
9.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
9.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
9.3.1. By Country
9.3.1.1. UK
9.3.1.2. Italy
9.3.1.3. Spain
9.3.1.4. Germany
9.3.1.5. France
9.3.1.6. BENELUX
9.3.1.7. Nordics
9.3.1.8. Rest of Europe
9.3.2. By Luminaire Type
9.3.3. By Component
9.3.4. By Supply Type
9.3.5. By Application
10. Asia Pacific LED
Driver Market Overview
10.1. Market Size (US$ Mn) Analysis, 2020 – 2035
10.2. Market Share (%) Analysis (2024 vs 2035),
Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness Analysis
(2025 - 2035)
10.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
10.3.1. By Country
10.3.1.1. China
10.3.1.2. Japan
10.3.1.3. India
10.3.1.4. South Korea
10.3.1.5. ASEAN
10.3.1.6. Australia & New Zealand
10.3.1.7. Rest of Asia Pacific
10.3.2. By Luminaire Type
10.3.3. By Component
10.3.4. By Supply Type
10.3.5. By Application
11. Middle East &
Africa LED Driver Market Overview
11.1. Market Size (US$ Mn) Analysis, 2020 – 2035
11.2. Market Share (%) Analysis (2024 vs 2035),
Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness Analysis
(2025 - 2035)
11.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
11.3.1. By Country
11.3.1.1. GCC
11.3.1.2. South Africa
11.3.1.3. Rest of Middle East & Africa
11.3.2. By Luminaire Type
11.3.3. By Component
11.3.4. By Supply Type
11.3.5. By Application
12. South America LED
Driver Market Overview
12.1. Market Size (US$ Mn) Analysis, 2020 – 2035
12.2. Market Share (%) Analysis (2024 vs 2035),
Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness Analysis
(2025 - 2035)
12.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Chile
12.3.1.3. Rest of South America
12.3.2. By Luminaire Type
12.3.3. By Component
12.3.4. By Supply Type
12.3.5. By Application
13. Country-Wise
Market Analysis
13.1. Growth Comparison by Key Countries
14. Competitive
Landscape
14.1. Market Share (%) Analysis, By Top Players
14.2. Market Structure Analysis, By Tier I &
II Companies
15. Company Profiles
15.1. Cree LED
15.1.1. Company Overview
15.1.2. Business Segments
15.1.3. Financial Insights
15.1.4. Key Business Aspects (Noise Analysis)
15.2. Microchip Technology Inc.
15.3. Cree LED
15.4. HLI SOLUTIONS, INC.
15.5. Signify Holding
15.6. SAMSUNG
15.7. Lutron Electronics Co., Inc.
15.8. MACROBLOCK, INC.
15.9. Analog Devices, Inc.
15.10. NXP Semiconductors
15.11. Semiconductor Components Industries, LLC
15.12. ams-OSRAM AG
15.13. ROHM CO., LTD.
15.14. STMicroelectronics
15.15. Texas Instruments Incorporated
16. Analysis &
Recommendations
16.1. Targeting Segment
16.2. Targeting Region
16.3. Market Approach
17. Research
Methodology
18. Disclaimer
